• Director, DeMatteis Cardiovascular Institute, St Francis Hospital and Heart Center
• Director, Angiographic Core Laboratory, CRF Clinical Trials Center

Dr. Ali received his medical degree with Honors and Distinction from the University of Sheffield and Doctorate in Cardiovascular Medicine Vascular Biology from the University of Oxford. Dr. Ali fulfilled a residency in internal medicine and fellowship in cardiovascular medicine at Stanford University Medical Center. He also served as Chief Fellow in cardiovascular intervention at Mount Sinai Medical Center. Prior to joining St Francis Hospital and Heart Center, Dr Ali was Associate Professor and Director of Intravascular Imaging and Physiology at Columbia University Medical Center.

• Director of Interventional Cardiology Research, St. Francis Hospital & Heart Center
  
• Associate Director of the Cardiac Catheterization Laboratory, St. Francis Hospital & Heart Center
  
• Director of the Physiology Core Laboratory, Cardiovascular Research Foundation 

Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high-volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is the author of more than 100 scientific articles, book chapters, and books on various aspects of intravascular imaging and coronary physiology. He is an Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital and has participated in major global studies that could impact future treatment strategies for coronary artery disease. He is the principal investigator of DEFINE PCI and DEFINE GPS, international studies assessing the improvement in blood flow after stent placement by coronary physiology, and FUSION, an OCT-based physiology assessment.

Director of Intravascular Imaging, St. Francis Hospital & Heart Center

Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital – The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on the steering committee for the pivotal IVUS trial, IMPROVE and SCAI’s Ischemic Heart Disease Council. Dr. Shlofmitz’s research interests have centered on intravascular imaging and physiology, calcified coronary artery disease and PCI optimization, with more than 100 publications in peer-reviewed journals.

• Chairman of Cardiology, St. Francis Hospital & Heart Center 

Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of OPCI. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr. Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, ILUMIEN IV, FUSION and Onyx 2.0, with more than 120 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.

• Director of Network Vascular Services, St. Francis Hospital
• Professor of Medicine, Tufts University School of Medicine

Dr. Garcia received his training in Cardiology at the University of Iowa Hospitals and Clinics in Iowa City, Iowa and as an interventional cardiologist at the Beth Israel Deaconess Medical Center, Harvard Medical School. Further, he received his peripheral vascular training at St. Elizabeth’s Medical Center, Tufts University, Boston, Massachusetts. Dr. Garcia then served at the Beth Israel Hospital as a full time interventional cardiologist and Director of the Peripheral Cardiovascular Program and Peripheral Interventions at the Beth Israel Deaconess Medical Center as well as the Director of the Interventional Fellowship Program and recently served at St. Elizabeth’s Medical Center as Chief of the Section of Interventional Cardiology and Vascular Medicine Programs for the past 15 years. He is a Professor of Medicine at Tufts University School of Medicine. He now, has joined Catholic Health Services in Long Island New York as Director of Network Vascular Services through St. Francis Hospital, one of the premier cardiovascular centers in the nation. Dr. Garcia continues his research interests in a wide variety of studies including peripheral vascular interventional trials and has served as national or global principal investigator on several trials. He is widely regarded as an expert in peripheral vascular disease and specifically in atherectomy for lower extremity revascularization. His work has been presented in numerous manuscripts, abstracts, textbooks and textbook chapters.

• Director of Interventional Electrosurgery, St. Francis Hospital
• Director of Cardiovascular Innovation, St. Francis Hospital
• Associate Director of Structural Heart Research, St. Francis Hospital

Jaffar Khan, MD is an Interventional Cardiologist at St Francis Hospital and Heart Center, Roslyn, where he is the Director of Interventional Electrosurgery, Director of Cardiovascular Innovation, and Associate Director of Structural Heart Research. He maintains an affiliation with the Laboratory of Cardiac Intervention at NHLBI, NIH, where he was previously a Staff Clinician. He has a special interest in structural heart disease innovation. Dr. Khan led the invention of transcatheter electrosurgical techniques to cut heart tissue, and together with a team of dedicated physicians and creative thinkers, invented several novel transcatheter procedures (LAMPOON, BASILICA, ELASTIC, SESAME, PASTA, Antepasta, TASTI and Khanno) that have been translated into clinical practice to help patients with mitral, aortic and tricuspid valve disease. He also contributed to the development of two devices that have completed early feasibility studies in the US (Mitral Cerclage Ventriculoplasty and Transcaval Closure Device). Dr. Khan received his undergraduate degree at Cambridge as a Scholar, medical degree at Oxford with merits, and an award-winning doctorate in cardiovascular sciences at King’s College London. He completed medical and general cardiology training in Oxford and London, and cardiology interventional fellowship at Washington Hospital Center. He received the NHLBI Director’s award, NHLBI Orloff award and NIH Director’s award, as well as the Young Investigator Awards at BCIS (UK) and AICS-PICS (USA). Dr. Khan is lead or associate investigator on 10 clinical 3 pre-clinical protocols. He has written over 130 peer-reviewed manuscripts and performed over 100 peer reviews. He is faculty at multiple international meetings and has given over 50 invited lectures, including 4 late breaking clinical trial presentations, as well as being a regular live case operator since 2016. His goal is to continue to contribute to device and procedure innovation and help bring these therapies to clinical practice to help patients.

• Director of Cardiovascular Imaging, Saint Francis Hospital and Catholic Health
• Director of Cardiovascular Imaging Research, Dematteis Institute
• Director, Advanced Cardiovascular Imaging Fellowship

Omar Khalique, MD, FACC, FASE, FSCCT, FSCMR, FSCAI is the Director of the Division of Cardiovascular Imaging at Saint Francis Hospital and Catholic Health, Director of Cardiovascular Imaging Research at the Dematteis Institute, and Director of the Advanced Cardiovascular Imaging Fellowship. Saint Francis Hospital is one of a handful of institutions in the country where all Cardiovascular Imaging modalities (Cardiac CT, Cardiac MRI, Echocardiography, Nuclear SPECT/PET) are unified under a single Division to form a comprehensive program. Dr. Khalique was previously with Columbia University Medical Center/New York Presbyterian Hospital, where he was an Associate Professor of Medicine (in Radiology) and served as the Director of Multimodality Cardiac Imaging at the Structural Heart and Valve Center. Dr. Khalique was one of the world’s first multimodality cardiovascular imaging specialists and is a recognized expert and thought leader in the fields of multimodality cardiovascular imaging and structural heart imaging. Dr. Khalique has published over 100 peer-reviewed manuscripts. He has served on the Journal of the American College of Cardiology’s (JACC) Cardiovascular Imaging expert panel on Imaging in Valvular Heart Disease and the American College of Cardiology’s Structural Heart Disease working group. Dr. Khalique serves on several important national research trial committees, including the PARTNER cardiovascular imaging publications committee, and the CONFIRM-2 steering committee. He has imaged for several first in human structural heart device implants and has directed core lab imaging trials for several early feasibility and pivotal clinical trials. Dr. Khalique is a regular speaker at local, national and international meetings including ACC, SCCT, SCAI, ASE, TVT, TCT, and CSI and serves on committees for several of these societies. He has been a co-author on several society position papers and guidelines. Dr. Khalique earned his medical degree at Sydney Kimmel Medical College. He did his Internal Medicine Residency and Cardiology Fellowship at New York Medical College. At Columbia University Medical Center, he underwent fellowship training in Advanced Echocardiography, Cardiovascular Computed Tomography and Interventional and Valvular Echocardiography. He also completed a fellowship in Cardiac Magnetic Resonance at Weill Cornell Medical Center.